QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Phase III Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK) POSITIVE NSCLC Patients: eXalt3 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15 作者:  Selvaggi, G.;  Wakelee, H. A.;  Mok, T.;  Wu, Y. -L.;  Reck, M. 收藏  |  浏览/下载：28/0  |  提交时间：2020/11/30 ALK plus NSCLC  ensartinib  Crizotinib   Progress on treatment of MET signaling pathway in non-small cell lung cancer 期刊论文 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020 作者:  Yu, Xiaoqing;  Yu, Sizhe;  Fan, Yun 收藏  |  浏览/下载：24/0  |  提交时间：2020/11/26 MET  Dysregulation  Overexpression  Amplification  Non-small cell lung cancer   Could Radiomic Signature Developed From NSCLC Patients Predict Overall Survival of Patients with ALK plus Mutation? 会议论文 作者:  Huang, L.;  Fan, M.;  Hu, W.;  Wang, J.;  Chen, J. 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Phase 3 study of first-line crizotinib vs pemetrexed-cisplatin/carboplatin (PCC) in East Asian patients (pts) with ALK plus advanced non-squamous non-small cell lung cancer (NSCLC). 期刊论文 2016, 卷号: 34, 期号: 15 作者:  Lu, Shun;  Mok, Tony;  Lu, You;  Zhou, Jianying;  Shi, Yuankai 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 Phase 3 study of first-line crizotinib vs pemetrexed-cisplatin/carboplatin (PCC) in East Asian patients (pts) with ALK plus advanced non-squamous non-small cell lung cancer (NSCLC). 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20 作者:  Lu, Shun;  Mok, Tony;  Lu, You;  Zhou, Jianying;  Shi, Yuankai 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 ASCEND-6: single-arm, open label, multicenter phase 1/2 study of ceritinib in Chinese pts with advanced ALK-rearranged (ALK plus ) non-small cell lung cancer (NSCLC) previously treated with crizotinib 期刊论文 2016, 卷号: 27 作者:  Zhang, L.;  Shi, Y.;  Tan, D. S. W.;  Hu, B.;  Xiaoqing, L. 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 Association of EGFR Mutation or ALK Rearrangement With Expression of DNA Repair and Synthesis Genes in Never-Smoker Women With Pulmonary Adenocarcinoma 期刊论文 http://dx.doi.org/10.1002/cncr.27603, 2012 Ren, Shengxiang; Chen, Xiaoxia; Kuang, Peng; Zheng, Limou; Su, Chunxia; Li, Jiayu; Li, Bing; Wang, Yongshen; Liu, Lu; Hu, Qiong; Zhang, Jie; Tang, Liang; Li, Xuefei; Zhou, Caicun; Schmid-Bindert, Gerald; 郑立谋 收藏  |  浏览/下载：4/0  |  提交时间：2015/07/22 CELL-LUNG-CANCER  GROWTH-FACTOR RECEPTOR  CISPLATIN PLUS GEMCITABINE  RANDOMIZED PHASE-III  ACTIVATING MUTATIONS  MESSENGER-RNA  CHEMOTHERAPY  GEFITINIB  ERCC1  MULTICENTER   RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non-Small-Cell Lung Cancer 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2012, 卷号: 30, 期号: 35, 页码: 4352-4359 作者:  Wang, R;  Hu, HC;  Pan, YJ;  Li, Y;  Ye, T 收藏  |  浏览/下载：45/0  |  提交时间：2015/07/22